dichloroacetic acid has been researched along with Experimental Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, K; Fischer, JW; Gorges, K; Gorski, DJ; Grandoch, M; Kretschmer, I; Reichert, C; Reiners, O; Twarock, S | 1 |
| Akazawa, T; Aoki, M; Inoue, N; Ito, Y; Kuze, B; Mizuta, K; Ohashi, T | 1 |
| Debus, J; Huber, PE; Kirsner, A; Peschke, P; Roeder, F; Weber, KJ; Zwicker, F | 1 |
| Choe, TB; Hong, SE; Jin, HO; Kim, EK; Kim, HA; Kim, JI; Lee, JK; Noh, WC; Park, IC; Seong, MK; Ye, SK | 1 |
| Chance, WT; Dayal, R; Friend, LA; James, JH | 1 |
| Andersen, ME; Boorman, GA; Brusick, DJ; Cohen, SM; Dragan, YP; Frederick, CB; Goodman, JI; Hard, GC; Meek, ME; O'Flaherty, EJ; Robinson, DE | 1 |
6 other study(ies) available for dichloroacetic acid and Experimental Neoplasms
| Article | Year |
|---|---|
Inhibition of the hyaluronan matrix enhances metabolic anticancer therapy by dichloroacetate in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Dichloroacetic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Extracellular Matrix; Humans; Hyaluronic Acid; Hymecromone; Male; Mice; Mice, Nude; Mitochondria; Molecular Structure; Neoplasms, Experimental; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity.
Topics: Animals; Arginase; Cell Line, Tumor; Dichloroacetic Acid; Female; Glycolysis; Interferon-gamma; Interleukin-17; Interleukin-23 Subunit p19; Lactic Acid; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Poly I-C; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase | 2013 |
Dichloroacetate induces tumor-specific radiosensitivity in vitro but attenuates radiation-induced tumor growth delay in vivo.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Dichloroacetic Acid; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Radiation Tolerance; Radiation-Sensitizing Agents; Rats; Treatment Outcome | 2013 |
Targeting HIF-1α is a prerequisite for cell sensitivity to dichloroacetate (DCA) and metformin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Dichloroacetic Acid; Dose-Response Relationship, Drug; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MCF-7 Cells; Metformin; Neoplasms, Experimental; Treatment Outcome | 2016 |
Elevated blood lactate is not a primary cause of anorexia in tumor-bearing rats.
Topics: Animals; Anorexia; Dichloroacetic Acid; Hypothalamus, Middle; Lactates; Male; Neoplasms, Experimental; Neuropeptide Y; Random Allocation; Rats; Rats, Inbred F344 | 2004 |
Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Chloroform; Dichloroacetic Acid; Guidelines as Topic; Humans; Neoplasms, Experimental; Risk Assessment; United States; United States Environmental Protection Agency | 2000 |